We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$11.3M +$186K +19,547 +2%
CAM
2
Cormorant Asset Management
Massachusetts
$6.27M
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.84M +$129K +13,578 +7%
EA
4
Emerald Advisers
Pennsylvania
$2.3M
BCM
5
Bridgeway Capital Management
Texas
$757K +$551K +58,000 New
AAM
6
Auxier Asset Management
Oregon
$660K
Geode Capital Management
7
Geode Capital Management
Massachusetts
$605K +$328K +34,517 +291%
BFA
8
BlackRock Fund Advisors
California
$336K +$84.2K +8,861 +53%
Northern Trust
9
Northern Trust
Illinois
$297K +$216K +22,779 New
Morgan Stanley
10
Morgan Stanley
New York
$233K +$73.8K +7,768 +77%
Citadel Advisors
11
Citadel Advisors
Florida
$218K +$158K +16,677 New
VKH
12
Virtu KCG Holdings
New York
$214K +$155K +16,363 New
BIT
13
BlackRock Institutional Trust
California
$136K
IA
14
IFP Advisors
Florida
$25K +$12.3K +1,300 +217%
BIM
15
BlackRock Investment Management
Delaware
$16K
Citigroup
16
Citigroup
New York
$13K +$9.5K +1,000 New
UBS Group
17
UBS Group
Switzerland
$13K +$9.5K +1,000 New
Wells Fargo
18
Wells Fargo
California
$7K +$3.8K +400 +400%
LTFS
19
Ladenburg Thalmann Financial Services
Florida
$1K
CG
20
Cutler Group
California
$1K +$950 +100 New
BNP Paribas Financial Markets
21
BNP Paribas Financial Markets
France
$13
RCM
22
RA Capital Management
Massachusetts
-$1.74M -253,468 Closed
NC
23
Nexthera Capital
New York
-$391K -57,100 Closed
AGM
24
Alpine Global Management
New York
-$113K -16,491 Closed
CS
25
Credit Suisse
Switzerland
-$111K -16,335 Closed